Abstract
We have reclassified 110 patients with autoantibody-positive cryptogenic chronic hepatitis according to the aggregate scoring system proposed by the International Autoimmune Hepatitis Group for signs of hepatitis C virus (HCV) infection and the newly proposed terminology of “unclassified” chronic hepatitis. Anti-HCV and HCV viremia were assessed by second-generation assays and reverse transcription-polymerase chain reaction. Immunomorphological and immunochemical characterizations of antinuclear, smooth muscle, liver-kidney microsomal type 1, and liver cytosol type 1 autoantibodies were also performed. All 45 anti-HCV negative patients fulfilled the score criteria for the diagnosis of “definite” or “probable” autoimmune hepatitis (AIH). Eight anti-HCV-positive cases reached the score of “probable” AIH, whereas the remaining 57 cases were diagnosed as unclassified chronic hepatitis. The scoring system allows the correct identification of all autoimmune cases without HCV infection. Autoimmune hepatitis runs a more severe disease course than unclassified chronic hepatitis, whose clinical and histological features are similar to those of autoantibody-negative chronic hepatitis C.
This is a preview of subscription content, log in via an institution to check access.
References
Czaja AJ: Diagnosis, prognosis, and treatment of classical autoimmune chronic active hepatitis.In Autoimmune Liver Diseases. EL Krawitt, RH Wiesner (eds). New York, Raven, 1991, pp 143–166
Lenzi M, Ballardini G, Fusconi M, Cassani F, Selleri L, Volta U, Zauli D, Bianchi FB: Type 2 autoimmune hepatitis and hepatitis C virus infection. Lancet 335:258–259, 1990
Garson JA, Lenzi M, Ring C, Cassani F, Ballardini G, Briggs M, Tedder RS, Bianchi FB: Hepatitis C viraemia in adults with type 2 autoimmune hepatitis. J Med Virol 34:223–226, 1991
Cassani F, Muratori L, Manotti P, Lenzi M, Fusconi M, Ballardini G, Selleri L, Volta U, Zauli D, Miniero R, Bianchi FB: Serum autoantibodies and the diagnosis of type-1 autoimmune hepatitis in Italy: a reappraisal at the light of hepatitis C virus infection. Gut 33:1260–1263, 1993
Lenzi M, Johnson PJ, McFarlane IG, Ballardini G, Smith HM, McFarlane BM, Bridger C, Vergani D, Bianchi FB, Williams R: Antibodies to hepatitis C virus in autoimmune liver disease: evidence for geographical heterogeneity. Lancet 338:277–280, 1991
Johnson PJ, McFarlane IG (convenors on behalf of the panel): Meeting report: International Autoimmune Hepatitis Group. Hepatology 18:998–1005, 1993
Anon: Terminology of chronic hepatitis, hepatic allograft rejection, and nodular lesions of the liver: Summary of recommendations developed by an International Working Party, supported by the World Congress of Gastroenterology. Los Angeles 1994. Am J Gastroenterol 89:177–181, 1994
Muratori L, Cataleta M, Muratori P, Manotti P, Lenzi M, Cassani F, Bianchi FB: Detection of anti-liver cytosol antibody type 1 (anti-LC1) by immunodiffusion, counterimmunoelectrophoresis and immunoblotting: Comparison of different techniques. J Immunol Methods 1995 (in press)
Cassani F, Bianchi FB, Lenzi M, Volta U, Pisi E: Immunomorphological characterization of antinuclear antibodies in chronic liver disease. J Clin Pathol 38:801–805, 1985
Fusconi M, Cassani F, Zauli D, Lenzi M, Ballardini G, Volta U, Bianchi FB: Anti-actin antibodies: A new test for an old problem. J Immunol Methods 130:1–8, 1990
Lunel F: Hepatitis C virus and autoimmunity: Fortuitous association or reality? Gastroenterology 107:1550–1555, 1994 (editorial)
Muratori L, Giostra F, Cataleta M, Francesconi R, Ballardini G, Cassani F, Lenzi M, Bianchi FB: Testing for hepatitis C virus sequences in peripheral blood mononuclear cells of patients with chronic hepatitis C in the absence of serum hepatitis C virus RNA. Liver 14:124–128, 1994
Lenzi M, Manotti P, Muratori L, Cataleta M, Ballardini G, Cassani F, Bianchi FB: Liver cytosolic 1 antigen-antibody system in type 2 autoimmune hepatitis and hepatitis C virus infection. Gut 36:749–754, 1995
Roarty TP, Gaffey MJ, Featherson PL, Caldwell SH, Dickson RC: Application of the International Autoimmune Hepatitis Group scoring system to chronic hepatitis C patients. Gastroenterology 106 (suppl 4):A969, 1994
Shindo M, Di Bisceglie AM, Hoofnagle JH: Acute exacerbation of liver disease during interferon alfa therapy for chronic hepatitis. Gastroenterology 102:1406–1408, 1992
Papo T, Marcellin P, Bernuau J, Durand F, Poynard T, Benhamou JP: Autoimmune chronic hepatitis exacerbated by alpha interferon. Ann Intern Med 116:51–53, 1992
Muratori L, Lenzi M, Cataleta M, Giostra F, Cassani F, Ballardini G, Zauli D, Bianchi FB: Interferon therapy in liver kidney microsomal antibody type 1-positive patients with chronic hepatitis C. J Hepatol 21:199–203, 1994
Zeniya M, Aizawa Y, Watanabe F, Kawabe T, Hara M, Sakaguchi M, Toda G: HCV-marker-positive autoimmune-type chronic active hepatitis: A possible relation between HCV infection and liver autoreactivity. Liver 14:206–212, 1994
Michel G, Ritter A, Gerken G, Meyer zum Buschenfelde K-H, Decker R, Manns MP: Anti-GOR and hepatitis C virus in autoimmune liver diseases. Lancet 339:267–269, 1992
Lunel F, Abuaf N, Frangeul L, Grippon P, Perrin M, Le Coz Y, Valla D, Borotto E, Yamamoto AM, Huraux JM, Opolon P, Homberg JC: Liver/kidney microsome antibody type 1 and hepatitis C virus infection. Hepatology 16:630–636, 1992
Manns MP, Griffin KJ, Sullivan KF, Johnson EF: LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxigenase. J Clin Invest 88:1370–1378, 1991
Muratori L, Lenzi M, Ma Y, Cataleta M, Mieli-Vergani G, Vergani D, Bianchi FB: Heterogeneity of liver kidney microsomal antibody type 1 in autoimmune hepatitis and hepatitis C virus-related liver disease. Gut 37:406–412, 1995
Author information
Authors and Affiliations
Additional information
Supported in part by the National MURST Project: Cirrosi epatica ed Epatiti virali.
Rights and permissions
About this article
Cite this article
Bianchi, F.B., Cassani, F., Lenzi, M. et al. Impact of International Autoimmune Hepatitis Group scoring system in definition of autoimmune hepatitis. Digest Dis Sci 41, 166–171 (1996). https://doi.org/10.1007/BF02208600
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02208600